By integrating sequence analysis, transcriptome profiling, cell viability assays and xenograft tumor growth inhibition studies, we explore the AR cistrome-activity relationship to render a global and dynamic view of its regulatory program upon small molecule antagonism. The gene discussed is AR; the disease is neoplasm.